Imidazoquinoline Resiquimod (R-848)
Fig-1: Chemical structure of Imidazoquinoline Resiquimod (R-848)
Roll over image to zoom in
Shipping Info:
Order now and get it on Tuesday August 16, 2022
Same day delivery FREE on San Diego area orders placed by 1.00 PM
| Amount : | 500 µg |
| Purification : | Purity≥98% |
| Content : | liquid (1 mg/ml) |
| Storage condition : | Store the product at 4°C for short term and at -20°C for long-term storage. Product is stable for 2 years at -20°C. |
| Alternative Name : | Resiquimod; S 28463; R848 |
Formula: C17H22N4O2
MW: 314.4
Immune response modifier. Potent antitumor and antiviral compound. Stimulates antibody secretion and cytokine production. Used as adjuvant to increase the effectiveness of vaccines, potent and selective synthetic ligand for Toll-like receptor 7 (TLR7) in mouse and for TLR7 and TLR8 in human Activates immune cells via the TLR7/TLR8 MyD88-dependent signaling pathway and leads to the induction of NF-κB, NLRP3/NALP3 inflammasome activator, independent of TLRs and RIG-I.Upregulator of the opioid growth factor receptor. Used in the treatment of skin lesions such as herpes simplex virus.
Solubility: Soluble in DMSO, dichloromethane or methanol. Slightly soluble in acetonitrile or ethyl acetate.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
![IL-2 Superkine (Fc) [IL-2 (human):Fc (human) (Recombinant)]](https://s3-us-west-2.amazonaws.com/abeomics/images/32-190051/1.jpg "IL-2 Superkine (Fc) [IL-2 (human):Fc (human) (Recombinant)]")
